1. Home
  2. RVMD vs WAL Comparison

RVMD vs WAL Comparison

Compare RVMD & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • WAL
  • Stock Information
  • Founded
  • RVMD 2014
  • WAL 1994
  • Country
  • RVMD United States
  • WAL United States
  • Employees
  • RVMD N/A
  • WAL N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • WAL Major Banks
  • Sector
  • RVMD Health Care
  • WAL Finance
  • Exchange
  • RVMD Nasdaq
  • WAL Nasdaq
  • Market Cap
  • RVMD 7.4B
  • WAL 8.3B
  • IPO Year
  • RVMD 2020
  • WAL 2005
  • Fundamental
  • Price
  • RVMD $39.40
  • WAL $72.33
  • Analyst Decision
  • RVMD Strong Buy
  • WAL Strong Buy
  • Analyst Count
  • RVMD 12
  • WAL 15
  • Target Price
  • RVMD $68.67
  • WAL $96.33
  • AVG Volume (30 Days)
  • RVMD 2.0M
  • WAL 885.1K
  • Earning Date
  • RVMD 05-07-2025
  • WAL 07-17-2025
  • Dividend Yield
  • RVMD N/A
  • WAL 2.10%
  • EPS Growth
  • RVMD N/A
  • WAL 6.13
  • EPS
  • RVMD N/A
  • WAL 7.28
  • Revenue
  • RVMD N/A
  • WAL $3,049,400,000.00
  • Revenue This Year
  • RVMD N/A
  • WAL $13.26
  • Revenue Next Year
  • RVMD $241.39
  • WAL $9.87
  • P/E Ratio
  • RVMD N/A
  • WAL $9.95
  • Revenue Growth
  • RVMD N/A
  • WAL 11.37
  • 52 Week Low
  • RVMD $29.17
  • WAL $56.70
  • 52 Week High
  • RVMD $62.40
  • WAL $98.10
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 51.81
  • WAL 47.07
  • Support Level
  • RVMD $36.53
  • WAL $69.89
  • Resistance Level
  • RVMD $40.00
  • WAL $74.58
  • Average True Range (ATR)
  • RVMD 1.80
  • WAL 1.89
  • MACD
  • RVMD -0.21
  • WAL -0.49
  • Stochastic Oscillator
  • RVMD 47.28
  • WAL 21.98

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

About WAL Western Alliance Bancorporation (DE)

Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.

Share on Social Networks: